» Articles » PMID: 37355611

Intersections Between Syndemic Conditions and Stages Along the Continuum of Overdose Risk Among Women Who Inject Drugs in Mexicali, Mexico

Overview
Journal Harm Reduct J
Publisher Biomed Central
Specialties Pharmacology
Psychiatry
Date 2023 Jun 24
PMID 37355611
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Research on women who inject drugs is scarce in low- and middle-income countries. Women experience unique harms such as sexism and sexual violence which translate into negative health outcomes. The present work aims to provide insight into the experiences of women who inject drugs at the US-Mexico border to identify social and health-related risk factors for overdose to guide harm reduction interventions across the Global South.

Methods: We recruited 25 women ≥ 18 years of age accessing harm reduction and sexual health services at a non-governmental harm reduction organization, "Verter", in Mexicali, Mexico. We employed purposeful sampling to recruit women who inject drugs who met eligibility criteria. We collected quantitative survey data and in-depth interview data. Analyses of both data sources involved the examination of descriptive statistics and thematic analysis, respectively, and were guided by the syndemic and continuum of overdose risk frameworks.

Results: Survey data demonstrated reports of initiating injection drug use at a young age, experiencing homelessness, engaging in sex work, being rejected by family members, experiencing physical violence, injecting in public spaces, and experiencing repeated overdose events. Interview data provided evidence of stigma and discrimination toward women, a lack of safe spaces and support systems, risk of overdose-related harms, sexual violence, and the overall need for harm reduction services.

Conclusion: Women who inject drugs in Mexicali describe experiences of violence, overdose, and public injecting. Women are particularly vulnerable in the Mexicali context, as this area faces a noticeable lack of health and social services. Evidenced-based harm reduction strategies such as safe consumption sites and overdose prevention strategies (e.g., naloxone distribution and training) may benefit this population. Evidence from local organizations could help close the gap in service provision in low-resource settings like Mexico, where government action is almost nonexistent.

Citing Articles

Spatial Heterogeneity in Fatal Overdose Rate Trends in Mexican Cities: 2005-2021.

Henson R, Mullachery P, Sanchez-Pajaro A, Cruz-Cruz C, Bilal U, Langellier B Am J Public Health. 2024; 114(7):705-713.

PMID: 38723222 PMC: 11153949. DOI: 10.2105/AJPH.2024.307650.

References
1.
Potier C, Laprevote V, Dubois-Arber F, Cottencin O, Rolland B . Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014; 145:48-68. DOI: 10.1016/j.drugalcdep.2014.10.012. View

2.
West B, Henry B, Agah N, Vera A, Beletsky L, Rangel M . Typologies and Correlates of Police Violence Against Female Sex Workers Who Inject Drugs at the México-United States Border: Limits of Decriminalization in Advancing Health and Human Rights. J Interpers Violence. 2020; 37(11-12):NP8297-NP8324. PMC: 8166925. DOI: 10.1177/0886260520975820. View

3.
Shirley-Beavan S, Roig A, Burke-Shyne N, Daniels C, Csak R . Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain. Harm Reduct J. 2020; 17(1):78. PMC: 7574529. DOI: 10.1186/s12954-020-00429-5. View

4.
Ataiants J, Mazzella S, Roth A, Robinson L, Sell R, Lankenau S . Multiple Victimizations and Overdose Among Women With a History of Illicit Drug Use. J Interpers Violence. 2020; 37(3-4):NP1588-NP1613. PMC: 7808297. DOI: 10.1177/0886260520927501. View

5.
Des Jarlais D, Feelemyer J, Modi S, Arasteh K, Hagan H . Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. Drug Alcohol Depend. 2012; 124(1-2):95-107. PMC: 3353009. DOI: 10.1016/j.drugalcdep.2011.12.020. View